David J. Hetzel

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Intravenous iron infusion and newer non-dextran formulations.

Intravenous iron infusion and newer non-dextran formulations.

Journal: The New Zealand medical journal

Published: April 30, 2021

Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.

Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease.

Journal: European journal of gastroenterology & hepatology

Published: May 05, 2018

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders.

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders.

Journal: Clinical and experimental gastroenterology

Published: July 29, 2016

Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial.

Cognitive-Behavioural Therapy for Inflammatory Bowel Disease: 24-Month Data from a Randomised Controlled Trial.

Journal: International journal of behavioral medicine

Published: July 20, 2016

Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial.

Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial.

Journal: BMC gastroenterology

Published: December 15, 2014

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy.

Journal: American journal of hematology

Published: December 06, 2013

Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.

Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study.

Journal: Journal of Crohn's & colitis

Published: April 23, 2013

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease.

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease.

Journal: PloS one

Published: October 25, 2012

Clinical audit: recent practice in caring for patients with acute severe colitis compared with published guidelines--is there a problem?

Clinical audit: recent practice in caring for patients with acute severe colitis compared with published guidelines--is there a problem?

Journal: Internal medicine journal

Published: August 09, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026